Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 30;40(3):407-412.
doi: 10.12122/j.issn.1673-4254.2020.03.20.

[Correlation between sarcopenia and albuminuria in patients with type 2 diabetes]

[Article in Chinese]
Affiliations

[Correlation between sarcopenia and albuminuria in patients with type 2 diabetes]

[Article in Chinese]
Junfeng Yan et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To investigate the correlation between sarcopenia and albuminuria in patients with type 2 diabetes mellitus (T2DM).

Methods: A total of 360 T2DM patients (including 206 male and 154 female patients) hospitalized in our hospital between January, 2015 and December, 2018 were enrolled. According to their medical history and laboratory test results, the patients were divided into albuminuria group (n=122) and non-albuminuria group (n=238). The clinical and anthropological data were collected and skeletal muscle index (SMI), appendage lean mass, muscle index, total body fat, bone mineral capacity and bone mineral density were measured using dual-energy X-ray absorptiometry. Logistic regression was used to analyze the correlation of these body composition parameters with albuminuria or chronic kidney disease (CKD) in the diabetic patients.

Results: The disease course of T2DM, history of hypertension, age, systolic blood pressure, low density lipoprotein cholesterol, triglyceride, uric acid, waistline, Urinary albumin creatinine ratio, serum creatinine, and glomerular filtration rate differed significantly between the diabetic patients with albuminuria and those without albuminuria (P < 0.05). The prevalence rate of sarcopenia was significantly higher in patients with albuminuria (31.4% vs 13.1%, P < 0.01). Compared with those without albuminuria, the patients with albuminuria had significantly decreased SMI (t=-2.304, P=0.021) and body mass index (Z=- 5.534, P < 0.01) and significantly increased total body fat (Z=- 2.838, P=0.005). Multivariate logistic regression analysis showed that after adjustment for age, gender, total body fat, smoking history, drinking history, duration of diabetes, HbA1c, history of hypertension, systolic blood pressure, low density lipoprotein cholesterol, body mass index, and triglyceride, the patients with a decreased SMI had a significantly increased risk of albuminuria (P=0.011 and 0.010), but SMI was not correlated with the risk of CKD in patients with T2DM (P > 0.05).

Conclusions: Sarcopenia is probably an independent risk factor for albuminuria in patients with T2DM.

目的: 探讨2型糖尿病(T2DM)患者肌肉减少症与2型糖尿病并发白蛋白尿的关系。

方法: 共纳入2015年1月~2018年12月期间于我住院治疗的T2DM患者360例(男性206例,女性154例),根据病史及相应辅助检查分为白蛋白尿组(n=122)、非白蛋白尿组(n=238)。收集临床资料,进行人体学测量,并以双能X线吸收法测定骨骼肌指数(SMI)、附肢肌质量,肌肉指数,总体脂,骨矿含量、骨密度。采用t检验、u检验、卡方检验进行统计学分析。采用logistic回归法分析身体成分与T2DM并发白蛋白尿或T2DM并发慢性肾脏病(CKD)的关系。

结果: 与非白蛋白尿组相比,白蛋白尿组患者T2DM病程、高血压病史、年龄、收缩压、低密度脂蛋白、甘油三酯、尿酸、腰围、尿白蛋白肌酐比、血肌酐及估算肾小球滤过率差异均有统计学意义(P < 0.05),且肌少症患病率更高(31.4% vs 13.1%,χ2值=16.207,P < 0.01)。身体成分方面,与非白蛋白尿患者相比,白蛋白尿组患者骨骼肌指数(t=-2.304,P=0.021)和体重指数(Z=-5.534,P < 0.01)显著降低,总体脂显著升高(Z=-2.838,P=0.005)。利用多元Logistics回归分析校正年龄、性别、总体脂、吸烟史、饮酒史、糖尿病病程、糖化血红蛋白、高血压病史、收缩压、低密度脂蛋白、体重指数与甘油三酯等混杂因素后,随着SMI降低,T2DM并发白蛋白尿风险显著升高(P=0.011和P=0.010),SMI与T2DM患CKD的风险无显著相关性(P > 0.05)。

结论: 肌少症降低,可能是T2DM并发白蛋白尿的独立危险因素。

Keywords: Type 2 diabetes; albuminuria; chronic kidney disease; risk factors; sarcopenia.

PubMed Disclaimer

Figures

1
1
肌少症患病率 Prevalence of sarcopenia (%). *P < 0.001.

Similar articles

Cited by

References

    1. Chun SW, Kim W, Choi KH. Comparison between grip strength and grip strength divided by body weight in their relationship with metabolic syndrome and quality of life in the elderly. PLoS One. 2019;14(9):e0222040. doi: 10.1371/journal.pone.0222040. [Chun SW, Kim W, Choi KH. Comparison between grip strength and grip strength divided by body weight in their relationship with metabolic syndrome and quality of life in the elderly[J]. PLoS One, 2019, 14(9): e0222040.] - DOI - PMC - PubMed
    1. Clark BC, Woods AJ, Clark LA, et al. The aging brain & the dorsal basal ganglia: implications for age-related limitations of mobility. Adv Geriatr Med Res. 2019;1 [Clark BC, Woods AJ, Clark LA, et al. The aging brain & the dorsal basal ganglia: implications for age-related limitations of mobility[J]. Adv Geriatr Med Res, 2019, 1.] - PMC - PubMed
    1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23. doi: 10.1093/ageing/afq034. [Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people[J]. Age Ageing, 2010, 39(4): 412-23.] - DOI - PMC - PubMed
    1. Foley RN, Wang C, Ishani A, et al. Kidney function and sarcopenia in the United States general population: NHANES Ⅲ. Am J Nephrol. 2007;27(3):279–86. doi: 10.1159/000101827. [Foley RN, Wang C, Ishani A, et al. Kidney function and sarcopenia in the United States general population: NHANES Ⅲ[J]. Am J Nephrol, 2007, 27(3): 279-86.] - DOI - PubMed
    1. Mesinovic J, Zengin A, De Courten B, et al. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019;12:1057–72. doi: 10.2147/DMSO.S186600. [Mesinovic J, Zengin A, De Courten B, et al. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship[J]. Diabetes Metab Syndr Obes, 2019, 12: 1057-72.] - DOI - PMC - PubMed

LinkOut - more resources